Condition
Steinert's Disease
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Recruiting3
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05532813Phase 3RecruitingPrimary
Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
NCT00082108Recruiting
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
NCT02398786Recruiting
Myotonic Dystrophy Family Registry
NCT02930408Not ApplicableTerminatedPrimary
Compare Train and 3D-4D Left Ventricular Systolic Function in Subjects Suffering From Dystrophy and Healthy Subjects
Showing all 4 trials